Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. Anti-ceacam5-sn 38
2. Immu-130
1. Labetuzumab-sn38
2. Unii-8e3hi6qq9j
3. Hmn14-sn38
4. Labetuzumab Govitecan [usan]
5. Immu 130
6. 8e3hi6qq9j
7. 1469876-18-3
8. Q27270244
| Molecular Weight | 1587.7 g/mol |
|---|---|
| Molecular Formula | C75H102N12O24S |
| XLogP3 | -3.6 |
| Hydrogen Bond Donor Count | 8 |
| Hydrogen Bond Acceptor Count | 30 |
| Rotatable Bond Count | 53 |
| Exact Mass | 1586.68506334 g/mol |
| Monoisotopic Mass | 1586.68506334 g/mol |
| Topological Polar Surface Area | 498 Ų |
| Heavy Atom Count | 112 |
| Formal Charge | 0 |
| Complexity | 3130 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 3 |
| Undefined Atom Stereocenter Count | 1 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
ABOUT THIS PAGE
A IMMU 130 manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of IMMU 130, including repackagers and relabelers. The FDA regulates IMMU 130 manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. IMMU 130 API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A IMMU 130 supplier is an individual or a company that provides IMMU 130 active pharmaceutical ingredient (API) or IMMU 130 finished formulations upon request. The IMMU 130 suppliers may include IMMU 130 API manufacturers, exporters, distributors and traders.
IMMU 130 Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of IMMU 130 GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right IMMU 130 GMP manufacturer or IMMU 130 GMP API supplier for your needs.
A IMMU 130 CoA (Certificate of Analysis) is a formal document that attests to IMMU 130's compliance with IMMU 130 specifications and serves as a tool for batch-level quality control.
IMMU 130 CoA mostly includes findings from lab analyses of a specific batch. For each IMMU 130 CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
IMMU 130 may be tested according to a variety of international standards, such as European Pharmacopoeia (IMMU 130 EP), IMMU 130 JP (Japanese Pharmacopeia) and the US Pharmacopoeia (IMMU 130 USP).
LOOKING FOR A SUPPLIER?
